Electromagnetic Stimulation for the Treatment of Urge Urinary Incontinence and Overactive Bladder
NCT ID: NCT01464372
Last Updated: 2013-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
130 participants
INTERVENTIONAL
2011-10-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Investigational Device
Treatment using electrical field stimulation of peripheral nerves
Electrical Field Stimulation Device
Treatment with Electrical Field Stimulation Device
Sham Device
Control group using sham device to mimic sound and sensation of investigational device
Sham Nerve Stimulation Device
Use of the sham device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrical Field Stimulation Device
Treatment with Electrical Field Stimulation Device
Sham Nerve Stimulation Device
Use of the sham device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Urinary Frequency
Exclusion Criteria
* Neurogenic bladder
* Overflow Incontinence
* Functional Incontinence
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EMKinetics, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth Peters, MD
Role: PRINCIPAL_INVESTIGATOR
Birmingham Urologic Associates
Scott MacDiarmid, MD
Role: PRINCIPAL_INVESTIGATOR
Alliance Urology Specialists
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EMK0910
Identifier Type: -
Identifier Source: org_study_id